InsiderClue
Stocks · Health care · Pharmaceutical Preparations

HARROW, INC.

HROW Clue Score59
United States Fiscal year ends December CIK 0001360214 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Balanced

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Mark L Baum
12 Dec 2025
Chief Executive Officer
Exercised, kept
180,000
$3.95
$711.00K
Andrew R. Boll
12 Dec 2025
President and CFO
Exercised, kept
60,000
$3.95
$237.00K
Mark L Baum
21 Jul 2025
Chief Executive Officer
Exercised, kept
600,000
$7.87
$4.72M
John P. Saharek
11 Sep 2024
CEO of ImprimisRx
Exercised, kept
90,000
$7.37
$663.30K
John P. Saharek
1 Mar 2024
CEO of ImprimisRx
Exercised, kept
5,000
$8.75
$43.75K
Mark L Baum
20 Feb 2024
Chief Executive Officer
Exercised, kept
150,000
$10.67
$1.60M
Andrew R. Boll
20 Feb 2024
Chief Financial Officer
Exercised, kept
45,000
$10.67
$480.15K
John P. Saharek
20 Feb 2024
CEO of ImprimisRx
Exercised, kept
30,000
$10.67
$320.10K
Andrew R. Boll
7 Feb 2024
Chief Financial Officer
Exercised, kept
7,400
$7.71
$57.05K
Mark L Baum
7 Feb 2024
Chief Executive Officer
Exercised, kept
15,400
$7.71
$118.73K
Mark L Baum
3 Apr 2023
Chief Executive Officer
Exercised, kept
180,000
$8.99
$1.62M
Andrew R. Boll
31 Mar 2023
Chief Financial Officer
Exercised, kept
90,000
$6.00
$540.00K
Mark L Baum
20 Jan 2022
Chief Executive Officer
Exercised, kept
125,000
$2.40
$300.00K
Mark L Baum
22 Nov 2019
Chief Executive Officer
Exercised, kept indirect
156,000
$1.79
$279.24K
Andrew R. Boll
22 Nov 2019
Chief Financial Officer
Exercised, kept
39,000
$1.79
$69.81K
Andrew R. Boll
1 Feb 2018
Chief Financial Officer
Exercised, kept
30,000
$1.83
$54.90K
John P. Saharek
1 Feb 2018
Chief Commercial Officer
Exercised, kept
30,000
$1.83
$54.90K
Richard L Md Lindstrom
27 Apr 2017
Director
Exercised, kept indirect
100,000
$1.79
$179.00K
Mark L Baum
19 Dec 2016
Chief Executive Officer
Exercised, kept
200,000
$1.72
$344.00K
Show all 132 transactions →

What was left out

Form 4 filings counted 173
Amendments (4/A) skipped 4
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 38
Transactions with no price 0
Shares from compensation/vesting 8,988,354
Sales filed before the plan box existed 22
History held since 28 Apr 2008